Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Immunohistochemical Analysis of Midkine Expression in Preinvasive and Invasive Squamous Cell Neoplasia of the Uterine Cervix

´ëÇѺ´¸®ÇÐȸÁö 2007³â 41±Ç 2È£ p.79 ~ 86
ÃÖ¼®Áø, ¼ÛÀº¼·, ±è·ç½Ã¾Æ, ÇÑÁö¿µ, ±èÁعÌ, ÁÖ¿µÃ¤, ¹ÚÀμ­,
¼Ò¼Ó »ó¼¼Á¤º¸
ÃÖ¼®Áø ( Choi Suk-Jin ) 
ÀÎÇÏ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

¼ÛÀº¼· ( Song Eun-Seop ) 
ÀÎÇÏ´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
±è·ç½Ã¾Æ ( Kim Lucia ) 
ÀÎÇÏ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÇÑÁö¿µ ( Han Jee-Young ) 
ÀÎÇÏ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
±èÁع̠( Kim Joon-Mee ) 
ÀÎÇÏ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÁÖ¿µÃ¤ ( Chu Young-Chae ) 
ÀÎÇÏ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¹ÚÀμ­ ( Park In-Suh ) 
ÀÎÇÏ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Abstract


Background: Midkine (MK) is a member of the heparin-binding growth factor family. Overexpression of MK is observed not only in cancerous tissue but also in precancerous lesions of the colon and the prostate. Using immunohistochemical methods, we investigated MK expression in preinvasive and invasive neoplasia of the uterine cervix.

Methods: We performed im- munohistochemical analysis of archived cone biopsy and hysterectomy specimens from 161 squamous cell lesions of the uterine cervix (29 cervical intraepithelial neoplasia 1 (CIN1), 35 CIN2, 49 CIN3, 30 microinvasive squamous cell carcinomas (MIC), and 18 invasive squamous cell carcinoma). In addition, we examined if there is a correlation between MK expression and status of human papilloma virus infection determined by a commercially available DNA chip.

Results: None of the normal cervical mucosa showed MK immunostaining. The level of MK expression gradually increased according to the histologic grade. Moderate and strong expressions were most frequently observed in cervical tissue with CIN3 and MIC. MK immunostaining was more accentuated in the invasive border of MIC.

Conclusion: MK may play a functional role in the disease progression of cervical squamous cell neoplasia.

Å°¿öµå

Cervical intraepithelial neoplasia; Midkine; Immunohistochemistry; Human papillomavirus

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS